Evidence map›Paper›PMID 36645919›Full record

ArticleAging2023

Targeting mitochondria to extend physically active lifespan.

Bumsoo Ahn

Abstract readEditorial
In one paragraph

Article in Aging, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Bumsoo AhnGerontology and Geriatrics section, Department of Internal Medicine, Wake Forest School of Medicine, Winston-Salem, NC 27101, USA.

Funding

The role of unacylated ghrelin on age-associated progressive muscle weakness and cachexia elicited by cancerR00AG064143 · NIA · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI AHN, BUMSOO · 2022 to 2024
$839k
NIA NIH HHS R00 AG064143
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

LongevitySarcopeniaHumansMitochondriamitochondrianeurogenic atrophyperoxiredoxinretrograde effectsarcopenia

Identifiers

PMID36645919
PMCPMC9925687

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.